logo
AAT Bioquest

Serotonin 7 (5-HT7) receptor Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
(R)-3-((2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidin-1-yl)sulfonyl)phenolIC500.9 [1], 3.71 [2]
ClozapineKi12.59 [1], 48.0 [2]
SerotoninIC501.5 [1]
MethiothepinIC501.5 [1], 3.1 [2], 21.0 [3]
MethiothepinKi0.9 [1], 1.0 [2], 1.7 [3], 3.7 [4]
OlanzapineKi79.43 [1], 185.0 [2], 206.0 [3], 365.0 [4], 1000.0 [5]
2a-[4-(4-Phenylpiperazin-1-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-oneKi2.14 [1], 3.16 [2], 3.31 [3]
2a-[4-[4-(2-Methoxyphenyl)piperazin-1-yl]butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-oneKi2.14 [1], 5.01 [2], 5.13 [3]
ChlorpromazineKi10.72 [1], 27.0 [2], 31.62 [3], 119.0 [4]
RisperidoneKi0.4 [1], 1.0 [2], 4.3 [3], 10.0 [4]
MianserinIC50114.82 [1]
MianserinKi56.0 [1], 63.1 [2], 8010.0 [3]
SpiperoneKi19.95 [1], 110.0 [2]
4-Methyl-1-[2-[(2R)-1-(3-methylphenyl)sulfonylpyrrolidin-2-yl]ethyl]piperidineKi3.0 [1], 3.16 [2]
CID 10028436Ki2.0 [1], 3.2 [2]
2a-[4-(4-Cyclohexylpiperazin-1-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-oneKi1000.0 [1], 10000.0 [2], 100000.0 [3]
2a-[3-(4-Phenylpiperazin-1-yl)propyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-oneKi5.0 [1], 5.01 [2], 5.25 [3]
2-[4-[4-(2-Oxo-1,3,4,5-tetrahydrobenzo[cd]indol-2a-yl)butyl]piperazin-1-yl]benzonitrileKi3.8 [1], 3.98 [2]
2a-[4-(4-Pyridin-2-ylpiperazin-1-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-oneKi1.86 [1], 2.0 [2]
1-(2-Methoxy-phenyl)-4-(1-o-tolyl-1H-pyrrol-3-ylmethyl)-piperazineKi4.3 [1], 4.7 [2], 21.0 [3]
3-[3-(4-Benzhydrylpiperazin-1-yl)-2-hydroxypropyl]-5-(4-fluorophenyl)-5-methylimidazolidine-2,4-dioneIC501807.0 [1]
3-[3-(4-Benzhydrylpiperazin-1-yl)-2-hydroxypropyl]-5-(4-fluorophenyl)-5-methylimidazolidine-2,4-dioneKi79.0 [1]
HaloperidolKi316.23 [1], 408.0 [2], 1122.02 [3]
8-OH-DpatKi388.0 [1], 466.0 [2]
ZiprasidoneKi5.0 [1], 5.01 [2], 6.0 [3]
MesulergineIC50120.0 [1], 290.0 [2]
MesulergineKi7.94 [1]
6-[4-(2-Methylsulfanylphenyl)piperazin-1-yl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)hexanamideKi0.22 [1]
1-[4-(3,4-Dihydro-1H-isoquinolin-2-yl)butyl]-3H-indol-2-oneKi7.0 [1]
(2S)-1-(1-Naphthylsulfonyl)-2-[2-(4-methylpiperidino)ethyl]pyrrolidineKi10.0 [1], 398.11 [2], 400.0 [3]
2a-[2-(4-Phenylpiperazin-1-yl)ethyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-oneKi100.0 [1], 102.33 [2]
N-Methyl-N-[4-(3-methylpiperidin-1-yl)butan-2-yl]naphthalene-1-sulfonamideKi63.1 [1], 65.0 [2]
6-Chloro-2a-[4-[4-(4-chlorophenyl)-3,6-dihydro-2H-pyridin-1-yl]butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-oneKi7.24 [1]
N-Methyl-2-[2-[4-(2-oxo-1,3,4,5-tetrahydrobenzo[cd]indol-2a-yl)butyl]-3,4-dihydro-1H-pyrido[3,4-b]indol-9-yl]acetamideKi3.55 [1], 4.0 [2]
N-(Diaminomethylidene)-9-hydroxy-9-methylfluorene-2-carboxamide;hydrochlorideIC5059.0 [1]
N-(Diaminomethylidene)-9-hydroxy-9-methylfluorene-2-carboxamide;hydrochlorideKi4.3 [1]
2-Bromo-6-[2-(dimethylamino)ethylthio]pyridineKi4.1 [1], 37.0 [2]
2-Phenyl-6-[2-(dimethylamino)ethylthio]pyridineKi0.6 [1], 6.2 [2]
(3S)-2-[5-[4-(2-Phenylphenyl)piperazin-1-yl]pentanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxamideKi6.0 [1], 12.0 [2], 94.0 [3]
5-[4-(2-Phenylphenyl)piperazin-1-yl]-1-[(2S)-2-(piperidine-1-carbonyl)pyrrolidin-1-yl]pentan-1-oneKi5.0 [1], 20.0 [2], 91.0 [3]
QuetiapineKi63.1 [1], 1000.0 [2]
LysergideKi6.31 [1], 6.6 [2]
RitanserinKi15.85 [1], 45.0 [2]
MetergolineKi6.31 [1]
VortioxetineKi26.0 [1]
LatrepirdineKi7.94 [1], 8.0 [2]
5-Chloro-N-(4-methoxy-3-(piperazin-1-yl)phenyl)-3-methylbenzo[b]thiophene-2-sulfonamideKi260.0 [1], 3981.07 [2]
2-Bromolysergic acid diethylamideKi10.0 [1], 30.0 [2]
2-[1-(Benzenesulfonyl)-5-methoxyindol-3-yl]-N,N-dimethylethanamineKi600.0 [1], 1900.0 [2]
2-Ethyl-5-methoxy-N,N-dimethyltryptamineIC501500.0 [1]
2-Ethyl-5-methoxy-N,N-dimethyltryptamineKi300.0 [1]
N,N-Diallyl-5-methoxytryptamineKi16.98 [1], 89.13 [2]
3-Methyl-2-((R)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-11-yl)-benzonitrileKi1.0 [1], 3.79 [2]
(2S)-(+)-5-(1,3,5-Trimethylpyrazol-4-YL)-2-(dimethylamino)tetralinKi0.6 [1]
Indole, 3-(2-(dimethylamino)ethyl)-5-methoxy-2-methyl-Ki145.0 [1], 1260.0 [2]
1-[5-(4-Phenylpiperazin-1-yl)pentyl]benzo[cd]indol-2-oneKi89.0 [1]
(6S,14R)-6-Methoxy-6,13-dimethyl-13-azapentacyclo[12.3.1.05,17.07,16.010,15]octadeca-1(17),2,4,7(16),8,10(15)-hexaeneKi1.1 [1]
Piperazine, 1-(4'-methoxy(1,1'-biphenyl)-2-yl)-IC50438.0 [1]
Piperazine, 1-(4'-methoxy(1,1'-biphenyl)-2-yl)-Ki2.6 [1]
5-Chloro-N-[4-methoxy-3-(4-methylpiperazin-1-yl)phenyl]-3-methyl-1-benzothiophene-2-sulfonamideKi3162.28 [1]
(6R,14R)-6-Methoxy-6,13-dimethyl-13-azapentacyclo[12.3.1.05,17.07,16.010,15]octadeca-1(17),2,4,7(16),8,10(15)-hexaeneKi1.1 [1]
(2R)-1-(1-Naphthylsulfonyl)-2-[2-(4-methylpiperidino)ethyl]pyrrolidineKi10.0 [1]
3-{4-[4-(4-Chlorophenyl)-piperazin-1-yl]-butyl}-3-ethyl-6-fluoro-1,3-dihydro-2H-indol-2-oneKi0.79 [1]
N-[3-[4-(2-Methoxyphenyl)piperazin-1-yl]propyl]naphthalene-2-sulfonamideIC5020.0 [1]
N-[3-[4-(2-Methoxyphenyl)piperazin-1-yl]propyl]naphthalene-2-sulfonamideKi20.0 [1]
2,8-Dimethyl-5-phenethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoleKi0.15 [1], 0.25 [2]
3-[2-[4-[2-(4-Methoxyphenyl)phenyl]piperazin-1-yl]ethoxy]-N-(pyridin-4-ylmethyl)propanamideKi18.0 [1]
3-[2-[4-[2-(4-Methoxyphenyl)phenyl]piperazin-1-yl]ethoxy]-N-(pyridin-3-ylmethyl)propanamideKi23.8 [1]
3-[2-[4-[2-(4-Methoxyphenyl)phenyl]piperazin-1-yl]ethoxy]-N-(pyridin-2-ylmethyl)propanamideKi23.5 [1]
6-[4-[2-(4-Methoxyphenyl)phenyl]piperazin-1-yl]-N-(pyridin-4-ylmethyl)hexanamideKi11.2 [1]
6-[4-[2-(4-Methoxyphenyl)phenyl]piperazin-1-yl]-N-(pyridin-2-ylmethyl)hexanamideKi15.2 [1]
6-[4-[2-(4-Methoxyphenyl)phenyl]piperazin-1-yl]-N-(pyridin-3-ylmethyl)hexanamideKi12.7 [1]
2-Cyclohexyl-6-[2-(dimethylamino)ethylthio]pyridineKi0.7 [1]
2-[2-[6-(Trifluoromethyl)indol-1-yl]ethyl]-3,4,5,7,8,9,10,10a-octahydro-1H-pyrido[1,2-a][1,4]diazepineKi7.0 [1]
2-N-[2-(4-Fluorophenoxy)ethyl]-4-N-[(1S)-1-phenylethyl]pyridine-2,4-diamineKi0.2 [1]
3,4-Dibromo-N-methyl-N-[(2R)-4-(4-methylpiperidin-1-yl)butan-2-yl]benzenesulfonamideKi19.95 [1]
N-Methyl-N-[(2R)-4-[(3R)-3-methylpiperidin-1-yl]butan-2-yl]naphthalene-1-sulfonamideKi125.89 [1]
N-Methyl-N-[(2S)-4-[(3S)-3-methylpiperidin-1-yl]butan-2-yl]naphthalene-1-sulfonamideKi10000.0 [1]
3,4-Dichloro-N-methyl-N-[(2R)-4-(4-methylpiperidin-1-yl)butan-2-yl]benzenesulfonamideKi31.62 [1]
(2S)-1-(1-Naphthylsulfonyl)-2-[2-(4-methylpiperidino)ethyl]piperidineKi15.85 [1], 398.11 [2]
4,5-Dibromo-N-methyl-N-[(2R)-4-(4-methylpiperidin-1-yl)butan-2-yl]thiophene-2-sulfonamideKi15.85 [1]
N-Methyl-N-[(2S)-4-[(3R)-3-methylpiperidin-1-yl]butan-2-yl]naphthalene-1-sulfonamideKi1584.89 [1]
2a-[4-[4-(4-Fluorophenyl)-3,6-dihydro-2H-pyridin-1-yl]butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-oneKi3.55 [1]
2a-[4-(4-Phenylpiperidin-1-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-oneKi2.0 [1], 3.98 [2]
3-Ethyl-3-[4-[4-(4-fluorophenyl)-3,6-dihydro-2H-pyridin-1-yl]butyl]-1H-indol-2-oneKi1.19 [1], 1.2 [2]
3-{4-[4-(4-Chlorophenyl)-piperazin-1-yl]-butyl}-3-ethyl-1,3-dihydro-2H-indol-2-oneKi0.38 [1]
5,7-Dichloro-3-[4-[4-(4-chlorophenyl)piperazin-1-yl]butyl]-3-ethyl-1H-indol-2-oneKi9.5 [1], 10.13 [2]
3-{4-[4-(4-Chlorophenyl)-piperazin-1-yl]-butyl}-1,3-dihydro-2H-indol-2-oneKi0.38 [1], 7.0 [2]
3-Ethyl-3-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]-1H-indol-2-oneKi5.38 [1], 5.4 [2]
1-(2-Methoxyphenyl)-4-[1-(2-cyanophenyl)-1H-pyrrole-3-ylmethyl]piperazineKi5.4 [1]
3-[4-[4-(3-Chlorophenyl)piperazin-1-yl]butyl]-3-ethyl-5-fluoro-1H-indol-2-oneKi2.1 [1], 2.11 [2]
3-{4-[4-(3-Chlorophenyl)-piperazin-1-yl]-butyl}-1,3-dihydro-2H-indol-2-oneKi0.49 [1]
Methyl 2-(3-((4-(2-methoxyphenyl)piperazin-1-yl)methyl)-1H-pyrrol-1-yl)-3-methylbenzoateKi18.0 [1]
3-{4-[4-(4-Chlorophenyl)-piperazin-1-yl]-butyl}-3-ethyl-5-fluoro-1,3-dihydro-2H-indol-2-oneKi2.81 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ Serotonin 7 (5-HT7) receptor Inhibitors (IC50, Ki)." AAT Bioquest, Inc.20 Nov2024https://www.aatbio.com/data-sets/serotonin-7-5-ht7-receptor-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024November 20). Quest Database™ Serotonin 7 (5-HT7) receptor Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/serotonin-7-5-ht7-receptor-inhibitors-ic50-ki.
BibTeXEndNoteRefMan